Back
DICER1HGNC Autosomal dominantPubMedPhenotypic expansion

DICER1 Syndrome and Tumor Pathology: An Updated Review for Diagnostic Practice.

Riascos MC, Nosé VAdv Anat Pathol 2026 · June 2026
Relevance score
6/10
Disease / domain
DICER1 syndrome / tumor predisposition
Source
PubMed
PMID 42262359
Share on LinkedIn

Gene / mechanism

Updated tumor spectrum and diagnostic algorithm for DICER1 syndrome

Summary

This Advances in Anatomic Pathology review updates knowledge on DICER1 syndrome, an autosomal dominant tumor predisposition caused by pathogenic variants in the microRNA-processing gene DICER1. Since its initial description in families with pleuropulmonary blastoma, the phenotypic spectrum has expanded considerably: thyroid, Sertoli-Leydig tumors, cystic nephroma, pituitary blastoma, embryonal rhabdomyosarcoma of the cervix. A practical diagnostic algorithm for pathologists is proposed.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

DICER1 syndrome is often under-recognized due to its heterogeneous and rare tumor spectrum. A review targeting pathologists is welcome: they are often the first to see unusual surgical specimens that should trigger an oncogenetics referral. The proposed algorithm should help systematize this reflex.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 2/3Novelty 1/2Sample 0/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 1/1 → Total: 6/10

Keywords

DICER1tumor predisposition syndromepleuropulmonary blastomatumor spectrumpediatric oncogenetics

More articles on DICER1

Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime